These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34515014)

  • 1. Molecular and Metabolomic Investigation of Celecoxib Antiproliferative Activity in Mono-and Combination Therapy against Breast Cancer Cell Models.
    Bardaweel SK; Dahabiyeh LA; Akileh BM; Shalabi DD; AlHiary AK; Pawling J; Dennis JW; Rahman AMA
    Anticancer Agents Med Chem; 2022; 22(8):1611-1621. PubMed ID: 34515014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway.
    Wang G; Li J; Zhang L; Huang S; Zhao X; Zhao X
    Biochem Biophys Res Commun; 2017 Aug; 490(3):969-976. PubMed ID: 28666869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications and Efficacy of Aromatase Inhibitors in Combination and Monotherapy for the Treatment of Lung Cancer.
    Rahal BA; Bardaweel SK
    Anticancer Agents Med Chem; 2022; 22(18):3114-3124. PubMed ID: 35473535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
    Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells.
    Qorri B; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():4149-4167. PubMed ID: 33116404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer.
    Alqahtani AM; Chidambaram K; Pino-Figueroa A; Chandrasekaran B; Dhanaraj P; Venkatesan K
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1916-1927. PubMed ID: 33660801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative effects of selective cyclooxygenase-2 inhibitor modulated by nimotuzumab in estrogen-dependent breast cancer cells.
    Wang YX; Gao JX; Wang XY; Zhang L; Liu CM
    Tumour Biol; 2012 Aug; 33(4):957-66. PubMed ID: 22252523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.
    Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT
    Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
    Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
    Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy of calcitriol inhibits the proliferation of breast cancer cells: new concept of nonclassical function of calcitriol.
    Aljunidee KA; Bardaweel SK
    Horm Mol Biol Clin Investig; 2021 Nov; 43(2):199-205. PubMed ID: 34768317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
    Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL
    Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors enhance chemosensitivity, promote apoptosis, and suppress migration of breast cancer cells.
    Ihraiz WG; Ahram M; Bardaweel SK
    Acta Pharm; 2020 Jun; 70(2):179-190. PubMed ID: 31955147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines.
    Bocca C; Bozzo F; Bassignana A; Miglietta A
    Mol Cell Biochem; 2011 Apr; 350(1-2):59-70. PubMed ID: 21140284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Celecoxib as a Potential Inhibitor in the Treatment of Inflammatory Diseases - A Review.
    Cruz JV; Rosa JMC; Kimani NM; Giuliatti S; Dos Santos CBR
    Curr Med Chem; 2022; 29(17):3028-3049. PubMed ID: 34514981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell Lines.
    Friedrich M; Reichert K; Woeste A; Polack S; Fischer D; Hoellen F; Rody A; Köster F; Thill M
    Anticancer Res; 2018 Feb; 38(2):1201-1207. PubMed ID: 29374758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.
    Paul AG; Chandran B; Sharma-Walia N
    Transl Res; 2013 Jun; 161(6):447-68. PubMed ID: 23523954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
    Perumalsamy H; Sankarapandian K; Kandaswamy N; Balusamy SR; Periyathambi D; Raveendiran N
    Int J Biochem Cell Biol; 2017 Nov; 92():104-114. PubMed ID: 28958615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells.
    Ganesh R; Marks DJ; Sales K; Winslet MC; Seifalian AM
    World J Surg Oncol; 2012 Sep; 10():200. PubMed ID: 23013454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Estrogen Receptor Modulators (SERMs) Synergize with Cisplatin, Induce Apoptosis and Suppress Cellular Migration and Colony Formation of Lung Cancer Cells.
    Alsous L; Bardaweel S
    Anticancer Agents Med Chem; 2022; 22(9):1826-1836. PubMed ID: 35546505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib impairs primary human myoblast proliferation and differentiation independent of cyclooxygenase 2 inhibition.
    Matheny RW; Kolb AL; Geddis AV; Roberts BM
    Physiol Rep; 2022 Nov; 10(21):e15481. PubMed ID: 36325583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.